0.561 USD
-0.01 (-1.3%)
At close: Jan 29, 2026
0.5526 USD
-0.01 (-1.5%)
Pre-Market: 1/30/2026, 4:07:21 AM
HURA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. HURA has a bad profitability rating. Also its financial health evaluation is rather negative. HURA does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- HURA had negative earnings in the past year.
- In the past year HURA has reported a negative cash flow from operations.
- HURA had negative earnings in each of the past 5 years.
- In the past 5 years HURA always reported negative operating cash flow.
1.2 Ratios
- HURA has a Return On Assets of -170.33%. This is amonst the worse of the industry: HURA underperforms 86.48% of its industry peers.
- With a Return On Equity value of -260.88%, HURA is not doing good in the industry: 71.62% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -170.33% | ||
| ROE | -260.88% | ||
| ROIC | N/A |
ROA(3y)-224%
ROA(5y)-257.81%
ROE(3y)-832.26%
ROE(5y)-1280.11%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- HURA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for HURA has been reduced compared to 1 year ago.
- Compared to 5 years ago, HURA has more shares outstanding
- There is no outstanding debt for HURA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- HURA has an Altman-Z score of -10.65. This is a bad value and indicates that HURA is not financially healthy and even has some risk of bankruptcy.
- HURA has a worse Altman-Z score (-10.65) than 72.95% of its industry peers.
- HURA has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
- HURA has a Debt to Equity ratio of 0.03. This is comparable to the rest of the industry: HURA outperforms 42.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -10.65 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 0.40 indicates that HURA may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.40, HURA is doing worse than 91.24% of the companies in the same industry.
- HURA has a Quick Ratio of 0.40. This is a bad value and indicates that HURA is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Quick ratio value of 0.40, HURA is not doing good in the industry: 90.67% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.4 | ||
| Quick Ratio | 0.4 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 65.62% over the past year.
EPS 1Y (TTM)65.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- The Earnings Per Share is expected to grow by 32.17% on average over the next years. This is a very strong growth
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-36.96%
EPS Next 2Y-4.26%
EPS Next 3Y-8.03%
EPS Next 5Y32.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- HURA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HURA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- HURA's earnings are expected to decrease with -8.03% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.26%
EPS Next 3Y-8.03%
5. Dividend
5.1 Amount
- No dividends for HURA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TUHURA BIOSCIENCES INC / HURA FAQ
What is the fundamental rating for HURA stock?
ChartMill assigns a fundamental rating of 1 / 10 to HURA.
What is the valuation status for HURA stock?
ChartMill assigns a valuation rating of 0 / 10 to TUHURA BIOSCIENCES INC (HURA). This can be considered as Overvalued.
Can you provide the profitability details for TUHURA BIOSCIENCES INC?
TUHURA BIOSCIENCES INC (HURA) has a profitability rating of 0 / 10.
How sustainable is the dividend of TUHURA BIOSCIENCES INC (HURA) stock?
The dividend rating of TUHURA BIOSCIENCES INC (HURA) is 0 / 10 and the dividend payout ratio is -0.01%.